SurgihoneyRO™ is a cutting-edge technology, an antimicrobial wound gel utilising bioengineered honey to deliver Reactive Oxygen Species (ROS).
SurgihoneyRO™ provides enhanced healing and a powerful antimicrobial action to reduce the microbial load thus removing the barriers to wound healing. Unlike other medical grade honeys, SurgihoneyRO™ has been bioengineered to enhance and precisely control its antimicrobial potency.
- Kills a wide range of bacteria in vitro [1,2,3]
- Prevents biofilm in vitro [1]
- Fast acting antimicrobial action [2]
- Substantially eradicates mature biofilm in vitro [4,5]
- Effective against multi drug-resistant microorganisms commonly found in chronic wounds [6]
- Effective debridement
- Assists the natural wound healing environment and promotes new tissue growth
SurgihoneyRO™ is the only antimicrobial wound dressing to be successfully tested against the WHO priority pathogens. [6]
For more information about SurgihoneyRO™ and information on how to buy, please follow this link to H&R Healthcare.
References
1.Halstead F, Webber M, Rauf M, Burt R, Dryden M, Oppenheim B. In vitro activity of an engineered honey, standard medical-grade honeys and antimicrobial wound dressings against biofilm-producing clinical bacterial isolates. Journal of Wound Care, Feb 2016.
2.Dryden M. Lockyer G. Kordo S. Cooke J. Engineered honey: in vitro antimicrobial activity of a novel topical wound care treatment. Journal of Global Antimicrobial Resistance 2014. 10.1016/j.jgar.2014.03.006.
3.Dryden M, Milward G, Saeed K. Infection prevention in wounds with SurgihoneyRO™. Journal of Hospital Infection 2014.Oct;88(2): 121-2.doi:10.1016/j. jhin.2914.07.008.Epub 2014 Aug1.
4.Perfectus Biomed report May 2017, data on file.
5.Halstead F, Use of an engineered honey to eradicate pre-formed biofilms of important wound pathogens: an in vitro study, Journal of Wound Care, 2017.
6.Perfectus Biomed report 2018, data on file.
